AMG National Trust Bank
NMRA icon

AMG National Trust Bank’s Neumora Therapeutics NMRA Stock Holding History

AMG National Trust Bank’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.7K Hold
43,379
– – ﹤0.01% 443
2026
Q1 		$84.6K Hold
43,379
– – ﹤0.01% 475
2025
Q4 		$77.6K Hold
43,379
– – ﹤0.01% 451
2025
Q3 		$79K Hold
43,379
– – ﹤0.01% 451
2025
Q2 		$31.8K Hold
43,379
– – ﹤0.01% 445
2025
Q1 		$43.4K Hold
43,379
– – ﹤0.01% 440
2024
Q4 		$480K Buy
+43,379
New +$520K 0.01% 344

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellcome Trust
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Iconiq Capital
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

AMG National Trust Bank's NMRA Position: Q2 2026 in Review

AMG National Trust Bank held its Neumora Therapeutics (NMRA) position steady in Q2 2026 at 43,379 shares worth $73.7K. The position accounts for ﹤0.01% of the portfolio, ranked #443.

AMG National Trust Bank first reported a position in NMRA in Q4 2024 and has held it in 7 quarters since. The position peaked at $480K in Q4 2024. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • AMG National Trust Bank held 43,379 shares of Neumora Therapeutics worth $73.7K as of Q2 2026.
  • AMG National Trust Bank left its Neumora Therapeutics share count unchanged in Q2 2026.
  • Neumora Therapeutics made up ﹤0.01% of AMG National Trust Bank's portfolio in Q2 2026, its #443 holding.
  • AMG National Trust Bank first reported a position in Neumora Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • AMG National Trust Bank's Neumora Therapeutics position peaked at $480K in Q4 2024.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on AMG National Trust Bank's 13F filing for Q2 2026, filed 7 Aug 2026.